Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07124741 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prognostic Power of the VEXUS Score in Septic Shock: Effectiveness in Mortality Prediction

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 5 months later Jun 30, 2026 → Nov 30, 2026
See other at-risk trials from Antalya Training and Research Hospital

Record History

See every version on ClinicalTrials.gov ↗

  1. Recruitment opened Show 5 more changesShow less
    • Primary completion pushed from Jun 30, 2026 to Nov 30, 2026
    • Study completion pushed from Aug 2026 to Dec 20, 2026
    • Study sites: 0 to 1
    • Eligibility criteria expanded, about 12 words
    • Study description expanded, about 4 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to evaluate the prognostic power of the VEXUS Score in predicting mortality among patients with septic shock in intensive care units.
Trial Details
NCT Number NCT07124741
Lead Sponsor Antalya Training and Research Hospital
Conditions
(from sponsor)		 Septic Shock, VExUS
Related terms Shock, Septic
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov